Helius Medical Technologies, Inc. financial data

Symbol
HSDT on Nasdaq, HSDTW on OTC
Location
642 Newtown Yardley Road, Newtown, PA
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 14, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 268 % -38.3%
Quick Ratio 54.4 % +73.2%
Debt-to-equity 68.6 % -46.2%
Return On Equity -700 % -171%
Return On Assets -415 % -266%
Operating Margin -4.93K % -142%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 1.08M shares -69.9%
Common Stock, Shares, Outstanding 680K shares -78.7%
Entity Public Float 3.09M USD -41.2%
Common Stock, Value, Issued 1K USD -66.7%
Weighted Average Number of Shares Outstanding, Basic 123K shares -96.3%
Weighted Average Number of Shares Outstanding, Diluted 123K shares -96.3%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 295K USD -50.3%
Revenue from Contract with Customer, Excluding Assessed Tax 252K USD -54.2%
Research and Development Expense 3.77M USD +24.4%
Operating Income (Loss) -14.6M USD -20.4%
Nonoperating Income (Expense) -6.74M USD -307%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -21.3M USD -141%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -21.3M USD -141%
Earnings Per Share, Basic 403 USD/shares +83.6%
Earnings Per Share, Diluted 403 USD/shares +83.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 6.08M USD -4.84%
Accounts Receivable, after Allowance for Credit Loss, Current 12K USD -90.1%
Inventory, Net 1.14M USD +39%
Assets, Current 7.8M USD -9.7%
Property, Plant and Equipment, Net 90K USD -45.5%
Operating Lease, Right-of-Use Asset 11K USD -78.8%
Intangible Assets, Net (Excluding Goodwill) 2K USD -93.5%
Assets 7.89M USD -10.8%
Accounts Payable, Current 1.29M USD +0.39%
Liabilities, Current 1.81M USD -12.3%
Operating Lease, Liability, Noncurrent 12K USD -78.6%
Liabilities 1.87M USD -25.5%
Accumulated Other Comprehensive Income (Loss), Net of Tax -295K USD -20.4%
Retained Earnings (Accumulated Deficit) -185M USD -13%
Stockholders' Equity Attributable to Parent 6.03M USD -4.94%
Liabilities and Equity 7.89M USD -10.8%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -3.54M USD -17.8%
Net Cash Provided by (Used in) Financing Activities 3.56M USD +143%
Net Cash Provided by (Used in) Investing Activities -5K USD +73.7%
Common Stock, Shares Authorized 150M shares 0%
Common Stock, Shares, Issued 680K shares -78.7%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 21K USD
Deferred Tax Assets, Valuation Allowance 41.1M USD +9.33%
Deferred Tax Assets, Gross 41.1M USD +9.24%
Operating Lease, Liability 12K USD -78.9%
Depreciation 8K USD -11.1%
Payments to Acquire Property, Plant, and Equipment 5K USD -73.7%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -21.3M USD -153%
Lessee, Operating Lease, Liability, to be Paid 36K USD +2.86%
Property, Plant and Equipment, Gross 502K USD -6.52%
Operating Lease, Liability, Current 12K USD -73.3%
Lessee, Operating Lease, Liability, to be Paid, Year Two 12K USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year One 12K USD -47.8%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1K USD -50%
Deferred Tax Assets, Operating Loss Carryforwards 32.6M USD +6.5%
Amortization of Intangible Assets 24K USD -79.5%
Share-based Payment Arrangement, Expense 2.79M USD +77.2%